Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Expert Review of Molecular Diagnostics|July 14, 2025
Smaller, cheaper, faster: where next for liquid biopsies?Valerio Gristina, Francesco Pepe, Francesca Rita Ogliari, et al.
Cancer Cytopathology|December 30, 2020
Tumor mutational burden on cytological samples: A pilot studyFrancesco Pepe, Pasquale Pisapia, Valerio Gristina, et al.
Therapeutic Advances in Medical Oncology|October 3, 2022
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysisAntonio Galvano, Luisa Castellana, Valerio Gristina, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 4, 2023
Network approach in liquidomics landscapeDaniele Santini, Andrea Botticelli, Antonio Galvano, et al.
Critical Reviews in Oncology/Hematology|January 3, 2023
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visibleValerio Gristina, Maria La Mantia, Marta Peri, et al.
Pathologica|September 18, 2025
Part III - Post-analytical phaseSimonetta Buglioni, Davide Seminati, Rossella Bruno, et al.
Cancers|December 11, 2022
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective StudyValerio Gristina, Nadia Barraco, Maria La Mantia, et al.
Molecular Oncology|January 9, 2025
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective studyValerio Gristina, Viviana Bazan, Nadia Barraco, et al.
NPJ Precision Oncology|September 5, 2024
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumorsLorena Incorvaia, Tancredi Didier Bazan Russo, Valerio Gristina, et al.
Therapeutic Advances in Medical Oncology|February 23, 2023
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplayLorena Incorvaia, Gaetana Rinaldi, Giuseppe Badalamenti, et al.
Pageof 6